Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Sexually Transmitted Disease (STD) Self-Testing Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The sexually transmitted disease (std) self-testing market size has experienced robust growth in recent years. It is projected to increase from $1.52 billion in 2025 to $1.67 billion in 2026, growing at a compound annual growth rate (CAGR) of 9.9%. The market’s expansion in the past can be attributed to several factors, including insufficient awareness regarding STD testing, the social stigma linked to visiting clinics, a reliance on hospital-based testing, a scarcity of convenient testing alternatives, and the rising incidence of sexually transmitted diseases.
The sexually transmitted disease (std) self-testing market size is projected to experience robust expansion over the coming years. This market is set to reach $2.42 billion in 2030, showing a compound annual growth rate (CAGR) of 9.7%. This projected growth is primarily driven by the increasing adoption of digital health platforms, the integration of multi-sample at-home testing kits, escalating government awareness initiatives, a rise in telehealth consultations, and the ongoing development of rapid and accurate diagnostic technologies. Key trends during this forecast period include a growing demand for at-home std testing kits, heightened awareness of sexual health and the benefits of early diagnosis, an expansion in telehealth and remote consultation services, the broadening of online and retail pharmacy distribution channels, and the integration of multi-sample testing solutions (blood, urine, oral).
Get A Free Sample Report With In-Depth Market Insights:
Sexually Transmitted Disease (STD) Self-Testing Market Growth Backed By Core Demand Fundamentals
The sexually transmitted disease (STD) self-testing market is anticipated to expand due to the increasing occurrence of syphilis. Syphilis, a sexually transmitted infection, manifests as body sores and can result in severe health problems if left untreated. Its rise is linked to reduced consistent condom usage, particularly among populations engaging in high-risk sexual behaviors. At-home STD self-testing offers a discreet and convenient method for syphilis screening, facilitating prompt identification. Such early detection ensures timely treatment, thereby lessening complications and hindering its continued transmission. For example, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated around 209,253 syphilis cases in 2023, marking a 1% rise from 207,269 cases in 2022, according to figures released in September 2025. Consequently, the increasing prevalence of syphilis is a key factor propelling the expansion of the sexually transmitted disease (STD) self-testing market.
Sexually Transmitted Disease (STD) Self-Testing Market Segment Analysis: What Are The Core Market Categories?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
Sexually Transmitted Disease (STD) Self-Testing Market Growth Trends Reshaping The Competitive Landscape
Key entities within the STD self-testing market are prioritizing the development of advanced offerings, such as over-the-counter (OTC) sample collection kits, to encourage early identification and timely management of infections. Over-the-counter sample collection kits function as home diagnostic tools, enabling individuals to gather samples like urine or swabs without needing a prescription. They provide a convenient and private means for early infection detection, facilitating prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit permits individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the convenience and privacy of their homes. Users are able to mail their samples to the laboratory using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit offers highly accurate results, demonstrating sensitivity rates of up to 99.9% for HIV and 99.5% for syphilis. All samples undergo analysis in a CLIA-certified and CAP-accredited laboratory, which ensures adherence to rigorous federal and state quality benchmarks through consistent inspections.
Sexually Transmitted Disease (STD) Self-Testing Market Top Companies Driving Competitive Growth
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
View The Full Sexually Transmitted Disease (STD) Self-Testing Market Report:
Sexually Transmitted Disease (STD) Self-Testing Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model